Results 171 to 180 of about 68,932 (288)

Gonadotropin-releasing hormone agonists in assisted reproduction

Gynecological Endocrinology, 1995
G. Leyendecker, G. Kunz, H. J. Müller, W. Bernart, U. Mischeck   +4 more
openaire   +1 more source

Long-term outcomes of gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty. [PDF]

Ann Pediatr Endocrinol Metab
Hwangbo J, Kang E, Nam HK, Rhie YJ, Lee KH.   +4 more
europepmc   +1 more source

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy. [PDF]

World J Clin Cases, 2023
Choi HJ, Lee JH, Jung CS, Ryu JM, Chae BJ, Lee SK, Yu JH, Kim SW, Nam SJ, Lee JE, Jung YJ, Kim HY.   +11 more
europepmc   +1 more source

Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.

Fertility and Sterility, 2014
D. Griffin, R. Feinn, L. Engmann, J. Nulsen, T. Budinetz, C. Benadiva   +5 more
semanticscholar   +1 more source

Optimal timing for triggering oocyte maturation during in vitro fertilization cycles varies between gonadotropin-releasing hormone agonist and human chorionic gonadotropin use. [PDF]

F S Rep
Enatsu N, Furuhashi K, Otsuki J, Enatsu K, Okamoto E, Kokeguchi S, Shiotani M.   +6 more
europepmc   +1 more source

Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?

Fertility and Sterility, 2014
Jianzhi Ren, A. Sha, Dongmei Han, Ping Li, Jie Geng, Chaihui Ma   +5 more
semanticscholar   +1 more source

De Novo Graves' Disease in a 10-Year-Old Girl Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Idiopathic Central Precocious Puberty: A Case Report. [PDF]

Cureus
Fujita Y, Horimukai K, Kiyohara M, Takahata N.   +3 more
europepmc   +1 more source

Risk factors for empty follicle syndrome in assisted reproductive technology with gonadotropin-releasing hormone agonist trigger. [PDF]

Reprod Med Biol, 2023
Inoue D, Sakakibara Y, Ishida C, Kondo M, Mizuno R, Saito M, Shibuya S, Hashiba Y, Asada Y.   +8 more
europepmc   +1 more source

Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy [PDF]

, 2009
Philip J. Saylor, Nancy L. Keating, Matthew R. Smith   +2 more
core   +1 more source

A Comparative Study of Quality of Life and Oncologic Outcomes in Premenopausal Women with Hormone Receptor-Positive Breast Cancer: Bilateral Oophorectomy vs. Gonadotropin-Releasing Hormone Agonist Therapy. [PDF]

Cancers (Basel)
Erdemoglu E, Ruddy KJ, Buras MR, Quillen J, Couch FJ, Olson JE, Bozzuto LM, Larson NL, Yi J, Butler KA.   +9 more
europepmc   +1 more source